Odyssey Health (ODYY) Liabilities and Shareholders Equity (2014 - 2026)
Odyssey Health's quarterly Liabilities and Shareholders Equity came in at $721304.0 in Q1 2026, up 170.29% year-on-year from $266866.0 in Q1 2025, and up 402.22% quarter-over-quarter from $143622.0 in Q4 2025.
Odyssey Health has reported Liabilities and Shareholders Equity for 13 years, with the latest figure at $721304.0 in Q1 2026.
- For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 170.29% year-over-year to $721304.0; the trailing twelve-month figure through Jan 2026 stood at $1.1 million (down 92.69% YoY), and the FY2025 full-year result was $49723.0, down 91.52% from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 stood at $721304.0, up from $143622.0 in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $14.0 million in Q1 2024, with the low at $49723.0 in Q3 2025.
- Average Liabilities and Shareholders Equity over 5 years is $2.0 million, with a median of $463447.0 recorded in 2023.
- Year-over-year, Liabilities and Shareholders Equity jumped 3014.39% in 2024 and plunged 98.79% in 2025.
- Tracing ODYY's Liabilities and Shareholders Equity over 5 years: stood at $867723.0 in 2022, then fell by 29.47% to $612039.0 in 2023, then tumbled by 44.28% to $341045.0 in 2024, then plunged by 57.89% to $143622.0 in 2025, then surged by 402.22% to $721304.0 in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $721304.0 (Q1 2026), $143622.0 (Q4 2025), and $49723.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 10.74 Bn |
| 10 | Odyssey Health | - | - | - | 721,304.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 721,304.00 |
| Oct 31, 2025 | 143,622.00 |
| Jul 31, 2025 | 49,723.00 |
| Apr 30, 2025 | 164,508.00 |
| Jan 31, 2025 | 266,866.00 |
| Oct 31, 2024 | 341,045.00 |
| Jul 31, 2024 | 586,146.00 |
| Apr 30, 2024 | 13.58 Mn |
| Jan 31, 2024 | 14.05 Mn |
| Oct 31, 2023 | 612,039.00 |
| Jul 31, 2023 | 455,793.00 |
| Apr 30, 2023 | 435,908.00 |
| Jan 31, 2023 | 463,447.00 |
| Oct 31, 2022 | 867,723.00 |
| Jul 31, 2022 | 569,677.00 |
| Apr 30, 2022 | 619,104.00 |
| Jan 31, 2022 | 334,215.00 |
| Oct 31, 2021 | 931,813.00 |
| Jul 31, 2021 | 610,533.00 |
| Apr 30, 2021 | 1.45 Mn |
| Jan 31, 2021 | 138,761.00 |
| Oct 31, 2020 | 398,583.00 |
| Jul 31, 2020 | 105,584.00 |
| Apr 30, 2020 | 279,147.00 |
| Jan 31, 2020 | 309,129.00 |
| Oct 31, 2019 | 336,055.00 |
| Jul 31, 2019 | 536,445.00 |
| Apr 30, 2019 | 25,483.00 |
| Jan 31, 2019 | 22,422.00 |
| Oct 31, 2018 | 25,436.00 |
| Jul 31, 2018 | 27,459.00 |
| Apr 30, 2018 | 35,849.00 |
| Jan 31, 2018 | 2,748.00 |
| Oct 31, 2017 | 177,958.00 |
| Jul 31, 2017 | 159,255.00 |
| Apr 30, 2017 | 86,970.00 |
| Jan 31, 2017 | 74,867.00 |
| Oct 31, 2016 | 57,196.00 |
| Jul 31, 2016 | 68,405.00 |
| Apr 30, 2016 | 84,931.00 |
| Jan 31, 2016 | 1,554.00 |
| Oct 31, 2015 | 5,793.00 |
| Jul 31, 2015 | 5,350.00 |
| Jul 31, 2014 | 255,980.00 |